Navigation Links
Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
Date:3/11/2008

RIO DE JANEIRO, Brazil, March 11 /PRNewswire-FirstCall/ -- Amilpar (BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and Reuters: AMIL3.SA), the largest managed care organization in Brazil, announced today its consolidated results for the fourth quarter 2007 and full year of 2007. The Company's operational and financial information is presented on a consolidated basis and in Brazilian Reais, in accordance with Brazilian Corporate Law and the Accounts Chart of the Agencia Nacional de Saude - ANS (Brazil's National Health Agency).
To access the complete Press Release, access the Company's IR website.

2007 Highlights

-- Total membership stood at over 2.69 million at the end of December, a

34.0% increase compared to 2006.

-- Adjusted Operating Revenues totaled R$ 3,465.7 million, 32.2% more than

in 2006.

-- Adjusted EBITDA amounted to R$ 382.8 million, an increase of 101.0%

over 2006, accompanied by an adjusted EBITDA margin of 11.0%, up by 3.8

p.p.

-- The Medical Loss Ratio came to 68.1%, around 3.6 p.p. down from 2006.

-- The Company posted an annual adjusted Net Income of R$ 281.3 million,

excluding non-recurring items, a figure 115.7% higher than in 2006.

Conference Calls

English

March 12, 2008

12:00 (11:00 New York)

Phone: +1 (973) 935-8893

Code: 34933715

Portuguese

March 12, 2008

15:00 (14:00 New York)

Phone: +55 (11) 2188-0188

Code: Amil

2007 2006 4T07 4T06

HIGHLIGHTS Audited Proforma Var. Audited Proforma Var.

Total Number of

Members 2,689.3 2,007.1 34.0% 2,689.3 2,007.1 34.0%

Adjusted Operating

Revenue* (R$ million) 3,465.7 2,621.0 32.2% 953.9 701.0 36.1%

EBITDA* (R$ million) 382.8 190.4 101.0% 114.5 61.5 86.1%

EBITDA Margin* (%) 11.0% 7.2% 3.8p.p. 12.0% 8.8% 3.2p.p.

Medical Loss Ratio*(%) 68.1% 71.7% -3.6p.p. 67.6% 69.6% -2.0p.p.

Net Income* (R$ million) 281.3 130.4 115.7% 105.8 26.7 296.3%

Earnings per Share* 0.78 0.36 115.7% 0.29 0.07 296.3%

* Excluding non-recurring items

SHARE DETAILS

Our shares are traded on the Novo Mercado under the ticker AMIL3.

Total no. of Shares 360,422,900

Price on 12/31/07 R$ 16.30

Average daily traded volume R$ 6.9 million

Market Cap on 12/31/07 R$ 5.9 billion


'/>"/>
SOURCE Amilpar
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MEDRAD(R) Revenues Grow 10 Percent in 2007
2. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
3. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
4. Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent
5. Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns
6. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
7. Natural Nutrition Operating Subsidiary Reports Record 29% Increase in Revenues for 2007 of $17,460,000
8. Medical Services International Predicts Revenues for the Second Half of the Year
9. Cord Blood America Revenues Up 121 Percent in First Nine Months of 2007
10. Volcano Reports Record Third Quarter Revenues
11. Profarmas Gross Revenues Reached R$ 698.2 Million in the 3rd Quarter 2007, a 31.9% Growth Over the Same Period Last Year and Net Income Rose by 94.9%, Respectively
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: